Innovation Stage
Expo Hall, #1357

ACC.17 Media

ACC is excited present the Innovation Stage at ACC.17. This unique venue is your opportunity to enjoy a 30-minute, focused discussion in a relaxed setting that’s less classroom, more living room.

  Friday, March 17
  Friday, March 17
9:45 a.m. – 10:15 a.m.
Session title to be announced
Speakers to be announced
Sponsored by Sanofi-Regeneron
10:45 a.m. – 11:15 a.m.
Thrombosis - AFib: An Exploration in Risk Reduction
This lecture will present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.
Speaker to be announced
Sponsored by Janssen Pharmaceuticals, Inc.
12:30 p.m. – 1:00 p.m.
Thrombosis - DVT/PE: An Exploration in Risk Reduction
This lecture will discuss treatment options for patients with deep vein thrombosis and pulmonary embolism and how they can reduce the risk of recurrent thrombotic events.
Speaker to be announced
Sponsored by Janssen Pharmaceuticals, Inc.
1:30 p.m. – 2:00 p.m.
Thrombosis - AFib: An Exploration in Risk Reduction
This lecture will present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.
Speaker to be announced
Sponsored by Janssen Pharmaceuticals, Inc.
3:45 p.m. – 4:15 p.m.
Rhythm Control in Atrial Fibrillation: Modern Treatments for a Better Tomorrow
Atrial fibrillation has become a virtual epidemic with over 3 million patients in the U.S. alone affected. For some of these patients, current pharmacological therapies alone are not effective. We want to engage in a practical discussion about the diagnosis, progression, and treatment for atrial fibrillation by reviewing various patient cases. In addition to reviewing clinical information, we are going to discuss the patient management pathway for atrial fibrillation.
Speaker to be announced
Sponsored by Biosense Webster
 
  Saturday, March 18
  Saturday, March 18
9:45 a.m. – 10:15 a.m.
Session title to be announced
Speaker to be announced
Sponsored by Sanofi-Regeneron
12:30 p.m. – 1:00 p.m.
Know Your Patient Goals: Understanding the Goal-Oriented Approach in PAH (WHO Group 1)
When discussing PAH treatment options, what goals do you set for your adult PAH (WHO Group 1) patients? Dr. Hunter Champion will present and discuss cases targeting the NO-sGC-cGMP pathway and review a goal-oriented approach in PAH.
Hunter Champion, MD, PhD, FAHA; Southeastern Cardiology Associates
Sponsored by Bayer
1:30 p.m. – 2:00 p.m.
Doctor, I’m Dizzy: Clinical Perspectives of Neurogenic Orthostatic Hypotension
Neurogenic orthostatic hypotension (nOH) is an underdiagnosed disorder whose symptoms can be profoundly impactful. Presentations will include an overview of nOH and its symptoms along with a discussion of best practices in communication and common diagnostic approaches.
Brian Olshansky, MD, FACC; Adjunct Professor, Des Moines University; Professor Emeritus, University of Iowa; Electrophysiologist, Mercy Hospital North Iowa
Sponsored by Lundbeck
3:45 p.m. – 4:15 p.m.
Session title to be announced
Speaker to be announced
Sponsored by Amgen
 
  Sunday, March 19
  Sunday, March 19
9:45 a.m. – 10:15 a.m.
Managing the Risk of Contrast-Induced Acute Kidney Injury: Society Guidelines, Recommendations, and Treatment Options
Contrast-Induced Acute Kidney Injury is a common complication associated with invasive cardiac procedures. It is strongly associated with morbidity, mortality, and significantly increased health-care expenses. Please join us to learn about recent society guideline updates, screening high-risk populations, and details on best practices to reduce the risk of CI-AKI.
Anand Prasad, MD, FACC, FSCAI, RPVI; Associate Professor of Medicine, Freeman Heart Association Endowed Professor in CVD, Associate Program Director CVD Fellowship Dept. of Medicine, UT Health Science Center at San Antonio
Sponsored by Osprey Medical Inc.
12:30 p.m. – 1:00 p.m.
American Heart Association & American College of Cardiology: Moving Hospital Accreditation Ahead. Together.
Reducing gaps and disparities of cardiovascular patient care through AHA/ACC’s new Accreditation for Cardiovascular Center of Excellence. Join us to learn more about how AHA & ACC have come together to offer hospitals a new cardiovascular service line hospital accreditation program that focuses on all aspects of cardiac care.
Puja Patel, MS; National Senior Manager, Hospital Accreditation & Certification Programs, American Heart Association
Sponsored by ACC and AHA
Schedule is current as of February 10, 2017, and is subject to change. Please check back for updates.


*Innovation Stage presentations are not part of ACC.17, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Advertisement

ACC Logo
ACC.17 on Social Media:
      
2017 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us